SYNTA PHARMACEUTICALS CORP. Common Stock (par value $0.0001 per share) At the Market Issuance Sales AgreementCommon Stock • July 18th, 2014 • Synta Pharmaceuticals Corp • Pharmaceutical preparations • New York
Contract Type FiledJuly 18th, 2014 Company Industry JurisdictionSynta Pharmaceuticals Corp., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC, a Delaware limited liability company (“MLV”), as follows:
SYNTA PHARMACEUTICALS CORP. Common Stock (par value $0.0001 per share) At the Market Issuance Sales AgreementCommon Stock • May 8th, 2014 • Synta Pharmaceuticals Corp • Pharmaceutical preparations • New York
Contract Type FiledMay 8th, 2014 Company Industry JurisdictionSynta Pharmaceuticals Corp., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC, a Delaware limited liability company (“MLV”), as follows:
MANNKIND CORPORATION Common Stock (par value $0.01 per share) At-The-Market Issuance Sales AgreementCommon Stock • March 18th, 2013 • Mannkind Corp • Pharmaceutical preparations • New York
Contract Type FiledMarch 18th, 2013 Company Industry JurisdictionMannKind Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (“MLV”), as follows:
MILLER ENERGY RESOURCES, INC. Common Stock (par value $0.0001 per share) Preferred Stock (par value $0.0001 per share)Common Stock • October 12th, 2012 • Miller Energy Resources, Inc. • Crude petroleum & natural gas • New York
Contract Type FiledOctober 12th, 2012 Company Industry JurisdictionMILLER ENERGY RESOURCES, INC., a Tennessee corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (“MLV”), as follows:
SYNTA PHARMACEUTICALS CORP. Common Stock (par value $0.0001 per share) At the Market Issuance Sales AgreementCommon Stock • May 3rd, 2012 • Synta Pharmaceuticals Corp • Pharmaceutical preparations • New York
Contract Type FiledMay 3rd, 2012 Company Industry JurisdictionSynta Pharmaceuticals Corp., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC, a Delaware limited liability company (“MLV”), as follows: